In the Media

Newark, NJ
Thursday, April 21, 2011

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.



Newark, NJ
Thursday, April 21, 2011

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.



Newark, NJ
Thursday, April 21, 2011

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.



Newark, NJ
Thursday, April 21, 2011

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.



Newark, NJ
Thursday, April 21, 2011

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.



Express Pharma
Monday, March 21, 2011

Amway Corporation, one of the leading direct selling FMCG companies in the world, is seeking research collaborations in the areas of diabetes, women's health related problems, weight management, immunity and chronic diseases. The company is looking for patent holders, research institutes, universities and private companies working in these fields.

Amway research has more than 100 research collaborations with the likes of Vanderbilt University, University of California (UC)-Irvine, UC- Berkeley, UC-Riverside, Tohoku University, Japan, Yonsei University, Seoul, Rutgers Business School - Newark and New Brunswick, Kendall College of Art and Design, Michigan, Beijing Medical University, Johns Hopkins School of Medicine, Miami University, Sun Yat-sen University, China, DeVry Calgary, Michigan Tech, Monash University, Standford University, The University of IOWA and City University of London.

Read the full article ›



MBAS
Marysville, WA
Thursday, November 25, 2010

Certificate programs are not the same as university-affiliated degree programs, such as the pharmaceutical MBA offered through Rutgers Business School. Mahmud Hassan, PhD, professor of finance and economics and director of the Pharmaceutical MBA program at Rutgers Business School, in New Jersey, says the MBA helps prepare professionals who have bachelor’s or master’s degrees and three years or more experience in any kind of industry for management careers in the pharmaceutical industry.



PRLog.com
Newark, NJ
Friday, May 14, 2010

Just as the state of New Jersey is recognized as the nation's principal pharmaceutical hub, Rutgers Business School (RBS) has evolved as an academic leader in pharmaceutical management training and research. Through partnerships with global companies Bristol-Myers Squibb, Eisai, Johnson & Johnson, Merck, Novartis, Roche and Schering-Plough (now part of Merck), Rutgers has been offering a cutting-edge MBA in Pharmaceutical Management for 10 years.



NJBiz
Somerset, NJ
Tuesday, April 27, 2010

To remain a viable home for business, New Jersey needs to develop sector-specific strategies — especially for its life sciences industry, which faces competition from other states and globally, said Richard Bagger, chief of staff to Gov. Chris Christie, in remarks Monday at the 10th anniversary celebration of the pharmaceutical MBA program at Rutgers Business School, in Newark.



Saturday, April 17, 2010

Rutgers Business School's Blanche and Irwin Lerner Center for Pharmaceutical Management Program offers A Two Day Certificate Program in Pharmaceutical Management. This Program provides a framework for understanding the structure and competitive profile of the industry, and includes a review of key regulatory issues, applicable patent law, drug pricing and reimbursement including the design of prescription drug benefit plans, DTC advertising, mergers and acquisitions, public policy initiatives, and financial evaluation.



New York, NY
Sunday, April 4, 2010

Shareholders of Merck sued in 2004, contending that current and former company officers and directors had breached their fiduciary duties in the marketing of the painkiller Vioxx, causing investors to lose billions. Michael A. Santoro, an associate professor of business ethics at Rutgers Business School, was paid by the plaintiffs to help draft the settlement terms. "I would argue that every company, not only in the pharmaceutical sector, but also in other industries," he said, "should look at the settlement as a road map for things they need to revise in their own corporate governance."



New York, NY
Saturday, March 13, 2010

Bayer Corporation, the makers of Yaz birth control and pharmaceutical giant is at the center of lawsuits, alleging that their most popular form of contraceptive is causing serious health issues to otherwise healthy young women. "'The health questions and lawsuits may rattle consumer confidence, but the warnings from federal health authorities about advertising and quality control raise larger questions about Bayer's approach to complying with government rules,' said Michael A. Santoro, an associate professor at Rutgers Business School, who studied ethics in the pharmaceutical industry."



BusinessWire
Billerica, MA
Wednesday, February 17, 2010

Lantheus Medical Imaging, Inc. announced today the appointment of RBS Alumnus Robert A. Spurr (MBA) to the position of Vice President, Sales and Marketing. He joins Lantheus with more than 20 years of industry experience at Novartis Pharmaceuticals, Aventis Pharmaceuticals and most recently Ortho-McNeil®, a pharmaceuticals division of Johnson and Johnson, where he was Vice President Sales and Marketing, Institutional Franchise.



New York, NY
Tuesday, December 29, 2009

The percentage of business school students enrolled in specialized programs has risen about 4 percent each year since 2001, according to Daniel R. LeClair, the organization’s vice president for knowledge services. More than a fifth of business school students are now seeking such degrees. With major pharmaceutical firms like Merck and Johnson & Johnson headquartered in the state, Rutgers University in New Jersey offers an M.B.A. in pharmaceutical management.



Pharmasia
Newark, NJ
Thursday, December 4, 2008

According to Associate Professor Michael A. Santoro, who teaches courses on the ethical and legal aspects of the pharmaceutical industry, the U.S. and Chinese governments need to enforce international trade laws already in place to ensure product safety if pharmaceutical companies from both countries are to continue developing global supply chains. Santoro, speaking to an industry audience during a Dec. 2 presentation at the Lerner Center for Pharmaceutical Management, stressed the term “safe trade” to highlight the need for a greater focus on safety issues for free trade agreements and regulations between the U.S. and China.